medsynapse-hcp
Background Crohn’s disease (CD) is a chronic, relapsing inflammatory disorder of the gastrointestinal tract characterized by transmural inflammation leading to strictures, fistulae, and progressive bowel damage (1). Despite significant advances with biologic agents such as anti-TNF, anti-integrin, and IL-12/23 inhibitors, many patients experience s
Mirikizumab in Moderate-to-Severe Crohn’s Disease: A Phase 3 Randomized Controlled Trial Synopsis

Mirikizumab in Moderate-to-Severe Crohn’s Disease: A Phase 3 Randomized Controlled Trial Synopsis

Similar Content

Pancytopenia, a rare presentation of hyperthyroidism
Pancytopenia, a rare presentation of hyperthyroidism
830 Reached2 Comments
Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
1007 Reached2 Comments
Treatment of Recurrent Adult Medulloblastoma
Treatment of Recurrent Adult Medulloblastoma
2602 Reached1 Comments4 Likes
Total Hip Arthroplasty in a Patient with Congenital Insensitivity to Pain
Total Hip Arthroplasty in a Patient with Congenital Insensitivity to Pain
358 Reached4 Comments5 Likes
Chronic Cough in Adolescent
Chronic Cough in Adolescent
282 Reached1 Comments6 Likes